Prelude Capital Management, LLC Elanco Animal Health Inc Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $211,230 - $551,820	17,021 New	17,021 $211,000
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $207,359 - $259,415	-7,210 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$27.85 - $34.49 $200,798 - $248,672	7,210 New	7,210 $212,000
Q4 2020 Feb 16, 2021	SELL	$27.53 - $33.79 $94,152 - $115,561	-3,420 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$21.1 - $29.13 $699,296 - $965,426	-33,142 Reduced 90.65%	3,420 $96,000

Q2 2020 Aug 14, 2020	BUY	$18.94 - $24.93 $685,760 - $902,640	36,207 Added 10199.15%	36,562 $784,000
Q1 2020 May 15, 2020	BUY	$16.68 - $32.25 $5,921 - $11,448	355 New	355 $8,000
Q4 2018 Feb 14, 2019	SELL	$29.63 - $34.5 $19,763 - $23,011	-667 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $22,744 - $24,138	667 New	667 $23,000

407

473M

2.6M

916K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.74B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.